Journal article
Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada
Abstract
OBJECTIVE: To conduct a cost-effectiveness analysis of currently available nucleos(t)ide antiviral treatments (lamivudine, telbivudine, entecavir, and tenofovir) for chronic hepatitis B in Canada.
METHODS: Markov modeling was used to project the lifetime health benefits and costs associated with the antiviral treatments. The hypothetical patient population was hepatitis B e antigen-positive chronic hepatitis B-infected patients aged 34 years. …
Authors
He J; Bowen JM; Xie F; Goeree R
Journal
Value in Health, Vol. 15, No. 6, pp. 894–906
Publisher
Elsevier
Publication Date
September 2012
DOI
10.1016/j.jval.2012.06.005
ISSN
1098-3015